Evidence map›Paper›PMID 34075207›Full record

ArticleEuropean journal of human genetics : EJHG2021

A mosaic PIK3CA variant in a young adult with diffuse gastric cancer: case report.

Iris B A W Te Paske, José Garcia-Pelaez, Anna K Sommer, Leslie Matalonga, Teresa Starzynska, Anna Jakubowska, Solve-RD-GENTURIS group,, Rachel S van der Post, Jan Lubinski, Carla Oliveira and 2 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Solving the unsolved rare diseases in Europe.European journal of human genetics : EJHG · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 6 countries.

Iris B A W Te PaskeDepartment of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
José Garcia-Pelaezi3S, Institute for Research and Innovation in Health of the University of Porto, Porto, Portugal.
Anna K SommerInstitute of Human Genetics, University of Bonn, Bonn, Germany.ORCID 0000-0001-6850-9290
Leslie MatalongaCNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Teresa StarzynskaDepartment of Gastroenterology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0001-5573-2397
Anna JakubowskaDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0002-5650-0501
Solve-RD-GENTURIS group,
Rachel S van der PostDepartment of Pathology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
Jan LubinskiDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Carla Oliveirai3S, Institute for Research and Innovation in Health of the University of Porto, Porto, Portugal.
Nicoline HoogerbruggeDepartment of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.ORCID 0000-0003-2393-8141
Richarda M de VoerDepartment of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. Richarda.devoer@radboudumc.nl.ORCID 0000-0002-8222-0343
Radboud University Nijmegen · NLMedical Genetics Center · DEUniversity of Bonn · DEInstitut d'Investigació Biomédica de Bellvitge · ESPomeranian Medical University · PLUniversidade do Porto · PTUniversity of Cambridge · GBCentre for Genomic Regulation · ESTechnische Universität Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary diffuse gastric cancer (HDGC) is associated with germline deleterious variants in CDH1 and CTNNA1. The majority of HDGC-suspected patients are still genetically unresolved, raising the need for identification of novel HDGC predisposing genes. Under the collaborative environment of the SOLVE-RD consortium, re-analysis of whole-exome sequencing data from unresolved gastric cancer cases (n = 83) identified a mosaic missense variant in PIK3CA in a 25-year-old female with diffuse gastric cancer (DGC) without familial history for cancer. The variant, c.3140A>G p.(His1047Arg), a known cancer-related somatic hotspot, was present at a low variant allele frequency (18%) in leukocyte-derived DNA. Somatic variants in PIK3CA are usually associated with overgrowth, a phenotype that was not observed in this patient. This report highlights mosaicism as a potential, and understudied, mechanism in the etiology of DGC.

Indexed as

MosaicismAdultClass I Phosphatidylinositol 3-KinasesExome SequencingFemaleHumansMutation, MissenseStomach NeoplasmsClass I Phosphatidylinositol 3-KinasesPIK3CA protein, human

Identifiers

PMID34075207
PMCPMC8440670
OpenAlexW3164076840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.